RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

NCT04796350 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

2400

Enrollment

INDUSTRY

Sponsor class

Conditions

Fragility Fracture
Hip Fractures
Osteoporosis

Interventions

DEVICE: AGN1 LOEP treatment

Sponsor

AgNovos Healthcare, LLC

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]